论文部分内容阅读
目的将基础研究成果应用于临床,评价浙贝及其复方浙贝颗粒辅助化疗提高难治性急性白血病临床有效性与安全性。方法采用随机、双盲、多家医院同期对照临床研
Objective To apply the basic research findings to clinical trials and evaluate the clinical efficacy and safety of Zhejiang and its compound ZheBai granule adjuvant chemotherapy in the treatment of refractory acute leukemia. Methods Randomized, double-blind, multi-hospital controlled clinical study over the same period